About: Androstanolone is a research topic. Over the lifetime, 69 publications have been published within this topic receiving 1925 citations. The topic is also known as: stanolone & dihydrotestosterone.
TL;DR: Methyltrienolone (R 1881), 17beta-hydroxy-17alpha-methyl-estra-4,9,11-trien-3-one, a very active androgen, binds specifically to rat prostate cytosol with a higher affinity than androstanolone, and is thus a useful tool for the detection of elusive androgen receptors and for their study in human tumors where interference from plasma contamination has to be circumvented.
TL;DR: By exchanging bound endogenous hormone in rat prostate cytosol with labelled R 1881, it is possible to measure total (free anc occupied) binding sites in androgen receptor sites in human benign prostatic hypertrophy.
TL;DR: A prostatic cytosol receptor of high affinity for androstanolone, a major metabolite of testosterone in the prostate, displays interconvertibility of the heavy “8–9 S’ and light “KCl-5 S” conformations, and binds potent “anti-androgens” .
TL;DR: Androstanolone was more active than testosterone and also provoked epithelial hyperplasia which was seen only after high doses of testosterone, indicating that testosterone action may be related to its conversion to different active metabolites, and particularly to androStanolone and 3β-androstanediol.
TL;DR: The ability to transform testosterone into DHT is much higher in all structures examined (with the exception of the prostate) in prepuberal than in adult rats.